Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease

Abstract

Background

To report the neuro-ophthalmological findings in the TAFRO syndrome in a South American patient.

Methods

This is a case report of a patient with TAFRO syndrome.

Results

We present the case of a 66-year-old woman with TAFRO syndrome and multicentric Castleman disease, who developed ophthalmic manifestations, as a rare complication, including optic disk edema and serous retinal detachment, which improved with conventional therapy.

Conclusions

The optic disk edema could be present as a neuro-ophthalmological finding in TAFRO syndrome. To the best of our knowledge, this is the first report on the ophthalmic manifestations in the TAFRO syndrome.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Takai K, Nikkuni K, Shibuya H, Hashidate H (2010) Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51(5):320–325

    PubMed  Google Scholar 

  2. 2.

    Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y et al (2016) Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103(6):686–692

    Article  PubMed  CAS  Google Scholar 

  3. 3.

    Yasuda S, Tanaka K, Ichikawa A, Watanabe K, Uchida E, Yamamoto M et al (2016) Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy. Int J Hematol 104(4):512–518

    Article  PubMed  CAS  Google Scholar 

  4. 4.

    Simons M, Apor E, Butera JN, Treaba DO (2016) TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature. Case Rep Hematol 2016:4703608

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S et al (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53(1):57–61

    Article  PubMed  Google Scholar 

  6. 6.

    Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A et al (2015) Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol 4(1):3

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Abdo LA, Morin CP, Collarino RP, Cabane JP, Gatfosse MA (2014) First European case of TAFRO syndrome associated with Sjogren disease. Am J Intern Med 2(6):102–105

    Google Scholar 

  8. 8.

    Contardo D, Finocchietto P, Uehara T, Papini C, Deligiannis N, Darderes E et al (2015) TAFRO syndrome in a patient of south-american descent. EJCRIM. doi:10.12890/2015_000220

    Article  Google Scholar 

  9. 9.

    Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822–830

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Allegra A, Rotondo F, Russo S, Calabrò L, Maisano V, Bacci F et al (2015) Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis 55(3):206–207

    Article  PubMed  Google Scholar 

  11. 11.

    Takasawa N, Sekiguchi Y, Takahashi T, Muryoi A, Satoh J, Sasaki T (2016) A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A. Mod Rheumatol 14:1–5

    Article  Google Scholar 

  12. 12.

    Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91(2):220–226

    Article  PubMed  CAS  Google Scholar 

  13. 13.

    Kumar S, Sharma S (2015) Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome. Oxf Med Case Rep 3:237–240

    Article  Google Scholar 

  14. 14.

    Carbone A, Pantanowitz L (2016) TAFRO syndrome: an atypical variant of KSHV-negative multicentric Castleman disease. Am J Hematol 91(2):171–172

    Article  PubMed  Google Scholar 

  15. 15.

    Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T et al (2013) Japanese variant of multicentric Castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85

    Article  PubMed  Google Scholar 

  16. 16.

    Kawashima M, Usui T, Okada H, Mori I, Yamauchi M, Ikeda T et al (2015) TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol 20:1–5

    Google Scholar 

  17. 17.

    Kojima M, Nakamura N, Otuski Y, Itoh H, Ogawa Y, Kobayashi H et al (2008) Pulmonary lesion of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia appears to be a cause of lymphoplasmacytic proliferation of the lung: a report of five cases. Pathol Res Pract 204(3):185–190

    Article  PubMed  Google Scholar 

  18. 18.

    Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y (2016) TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol 17:1–6

    Article  Google Scholar 

  19. 19.

    Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D et al (2016) Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol 91(6):585–589

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alvaro Ortiz.

Ethics declarations

Ethics approval

All the scientific and ethical principles of the Helsinki Declaration on Human Research were respected.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Conflict of interest

The authors declare that there is no conflict of interest.

Funding

All the sources were provided by the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ortiz, A., Cárdenas, P., Peralta, M. et al. Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease. Int Ophthalmol 38, 1641–1646 (2018). https://doi.org/10.1007/s10792-017-0636-x

Download citation

Keywords

  • Optic nerve disease
  • Multicentric Castleman’s disease
  • Electrophysiology
  • Thrombocytopenia